Matthew J Resnick1, Daniel A Barocas2, Alicia K Morgans3, Sharon E Phillips4, Tatsuki Koyama4, Peter C Albertsen5, Matthew R Cooperberg6, Michael Goodman7, Sheldon Greenfield8, Ann S Hamilton9, Karen E Hoffman10, Richard M Hoffman11, Sherrie H Kaplan8, Dan McCollum12, Lisa E Paddock13, Janet L Stanford14, Antoinette M Stroup13, Xiao-Cheng Wu15, David F Penson16. 1. Department of Urologic Surgery, Vanderbilt University, Nashville, TN, USA; Geriatric Research Education and Clinical Center, VA Tennessee Valley Healthcare System, Nashville, TN, USA. Electronic address: Matthew.Resnick@vanderbilt.edu. 2. Department of Urologic Surgery, Vanderbilt University, Nashville, TN, USA. 3. Department of Medicine, Vanderbilt University, Nashville, TN, USA. 4. Department of Biostatistics, Vanderbilt University, Nashville, TN, USA. 5. Division of Urology, University of Connecticut Health Center, Farmington, CT, USA. 6. Department of Urology, University of California San Francisco, San Francisco, CA, USA. 7. Department of Epidemiology, Emory University, Atlanta, GA, USA. 8. Department of Medicine, University of California, Irvine, Irvine, CA, USA. 9. Department of Preventive Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. 10. Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. 11. Department of Medicine, University of New Mexico, Albuquerque, NM, USA. 12. Eskind Biomedical Library, Vanderbilt University, Nashville, TN, USA. 13. New Jersey State Cancer Registry, Trenton, NJ, USA. 14. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. 15. Louisiana State University Health Sciences Center, New Orleans, LA, USA. 16. Department of Urologic Surgery, Vanderbilt University, Nashville, TN, USA; Geriatric Research Education and Clinical Center, VA Tennessee Valley Healthcare System, Nashville, TN, USA.
Abstract
BACKGROUND: Despite the paramount importance of patient-reported outcomes, little is known about the evolution of patient-reported urinary and sexual function over time. OBJECTIVE: To evaluate differences in pretreatment urinary and sexual function in two population-based cohorts of men with prostate cancer enrolled nearly 20 yr apart. DESIGN, SETTING, AND PARTICIPANTS: Patients were enrolled in the Prostate Cancer Outcomes Study (PCOS) or the Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) study, two population-based cohorts that enrolled patients with incident prostate cancer from 1994 to 1995 and from 2011 to 2012, respectively. Participants completed surveys at baseline and various time points thereafter. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We performed multivariable logistic and linear regression analysis to investigate differences in pretreatment function between studies. RESULTS AND LIMITATIONS: The study comprised 5469 men of whom 2334 (43%) were enrolled in PCOS and 3135 (57%) were enrolled in CEASAR. Self-reported urinary incontinence was higher in CEASAR compared with PCOS (7.7% vs 4.7%; adjusted odds ratio [OR]: 1.83; 95% confidence interval [CI], 1.39-2.43). Similarly, self-reported erectile dysfunction was more common among CEASAR participants (44.7% vs 24.0%) with an adjusted OR of 3.12 (95% CI, 2.68-3.64). Multivariable linear regression models revealed less favorable self-reported baseline function among CEASAR participants in the urinary incontinence and sexual function domains. The study is limited by its observational design and possibility of unmeasured confounding. CONCLUSIONS: Reporting of pretreatment urinary incontinence and erectile dysfunction has increased over the past two decades. These findings may reflect sociological changes including heightened media attention and direct-to-consumer marketing, among other potential explanations. PATIENT SUMMARY: Patient reporting of urinary and sexual function has evolved and is likely contingent on continually changing societal norms. Recognizing the evolving nature of patient reporting is essential in efforts to conduct high-quality, impactful comparative effectiveness research.
BACKGROUND: Despite the paramount importance of patient-reported outcomes, little is known about the evolution of patient-reported urinary and sexual function over time. OBJECTIVE: To evaluate differences in pretreatment urinary and sexual function in two population-based cohorts of men with prostate cancer enrolled nearly 20 yr apart. DESIGN, SETTING, AND PARTICIPANTS: Patients were enrolled in the Prostate Cancer Outcomes Study (PCOS) or the Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) study, two population-based cohorts that enrolled patients with incident prostate cancer from 1994 to 1995 and from 2011 to 2012, respectively. Participants completed surveys at baseline and various time points thereafter. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We performed multivariable logistic and linear regression analysis to investigate differences in pretreatment function between studies. RESULTS AND LIMITATIONS: The study comprised 5469 men of whom 2334 (43%) were enrolled in PCOS and 3135 (57%) were enrolled in CEASAR. Self-reported urinary incontinence was higher in CEASAR compared with PCOS (7.7% vs 4.7%; adjusted odds ratio [OR]: 1.83; 95% confidence interval [CI], 1.39-2.43). Similarly, self-reported erectile dysfunction was more common among CEASAR participants (44.7% vs 24.0%) with an adjusted OR of 3.12 (95% CI, 2.68-3.64). Multivariable linear regression models revealed less favorable self-reported baseline function among CEASAR participants in the urinary incontinence and sexual function domains. The study is limited by its observational design and possibility of unmeasured confounding. CONCLUSIONS: Reporting of pretreatment urinary incontinence and erectile dysfunction has increased over the past two decades. These findings may reflect sociological changes including heightened media attention and direct-to-consumer marketing, among other potential explanations. PATIENT SUMMARY:Patient reporting of urinary and sexual function has evolved and is likely contingent on continually changing societal norms. Recognizing the evolving nature of patient reporting is essential in efforts to conduct high-quality, impactful comparative effectiveness research.
Authors: Arnold L Potosky; Bryce B Reeve; Limin X Clegg; Richard M Hoffman; Robert A Stephenson; Peter C Albertsen; Frank D Gilliland; Janet L Stanford Journal: J Natl Cancer Inst Date: 2002-03-20 Impact factor: 13.506
Authors: A L Potosky; L C Harlan; J L Stanford; F D Gilliland; A S Hamilton; P C Albertsen; J W Eley; J M Liff; D Deapen; R A Stephenson; J Legler; C E Ferrans; J A Talcott; M S Litwin Journal: J Natl Cancer Inst Date: 1999-10-20 Impact factor: 13.506
Authors: A L Potosky; J Legler; P C Albertsen; J L Stanford; F D Gilliland; A S Hamilton; J W Eley; R A Stephenson; L C Harlan Journal: J Natl Cancer Inst Date: 2000-10-04 Impact factor: 13.506
Authors: Brock O'Neil; Tatsuki Koyama; JoAnn Alvarez; Ralph M Conwill; Peter C Albertsen; Matthew R Cooperberg; Michael Goodman; Sheldon Greenfield; Ann S Hamilton; Karen E Hoffman; Richard M Hoffman; Sherrie H Kaplan; Janet L Stanford; Antoinette M Stroup; Lisa E Paddock; Xiao-Cheng Wu; Robert A Stephenson; Matthew J Resnick; Daniel A Barocas; David F Penson Journal: J Urol Date: 2015-09-03 Impact factor: 7.450
Authors: Athene Lane; Chris Metcalfe; Grace J Young; Tim J Peters; Jane Blazeby; Kerry N L Avery; Daniel Dedman; Liz Down; Malcolm D Mason; David E Neal; Freddie C Hamdy; Jenny L Donovan Journal: BJU Int Date: 2016-08-17 Impact factor: 5.588
Authors: Rebecca Roth; Sebastian Dieng; Alisa Oesterle; Günter Feick; Günther Carl; Andreas Hinkel; Thomas Steiner; Björn Theodor Kaftan; Frank Kunath; Boris Hadaschik; Simba-Joshua Oostdam; Rein Jüri Palisaar; Mateusz Koralewski; Burkhard Beyer; Björn Haben; Igor Tsaur; Simone Wesselmann; Christoph Kowalski Journal: World J Urol Date: 2020-02-10 Impact factor: 4.226